EBNA-1 AND BZLF1 PLUS IGG SERUM LEVELS INDIVIDUATE EARLY STAGES OF EPSTEIN-BARR-VIRUS (EBV)-RELATED POST TRANSPLANT LYMPHOPROLIFERATIVE DISEASE (PTLD) AND HELPS MODULATION OF IMMUNE SUPPRESSION (IS) IN LIVER-TRANSPLANT RECIPIENTS

Citation
F. Migliaro et al., EBNA-1 AND BZLF1 PLUS IGG SERUM LEVELS INDIVIDUATE EARLY STAGES OF EPSTEIN-BARR-VIRUS (EBV)-RELATED POST TRANSPLANT LYMPHOPROLIFERATIVE DISEASE (PTLD) AND HELPS MODULATION OF IMMUNE SUPPRESSION (IS) IN LIVER-TRANSPLANT RECIPIENTS, Hepatology, 28(4), 1998, pp. 423-423
Citations number
NO
Categorie Soggetti
Gastroenterology & Hepatology
Journal title
ISSN journal
02709139
Volume
28
Issue
4
Year of publication
1998
Part
2
Supplement
S
Pages
423 - 423
Database
ISI
SICI code
0270-9139(1998)28:4<423:EABPIS>2.0.ZU;2-F